RxDoctor Payments DataLook up a doctor →

Navid Ezra, MD

Dermatology · Thousand Oaks, CANPI 1104110071

Payments from drug & device makers

$7,752,047in general payments, 2019–2025

Across 2,236 payments — averaging $3466.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.5M
  • Amgen$1.1M
  • Pfizer$913K
  • Takeda Pharmaceuticals U.S.A., Inc.$909K
  • Incyte Corporation$723K
  • UCB SA$651K
  • plus $2M from 46 others
$37,027in research payments, 2019–2025

Across 25 payments — averaging $1481.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$25K
  • X4 Pharmaceuticals, Inc.$7K
  • Bausch Health US, LLC$3K
  • AbbVie$3K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie484$1,485,525
Amgen231$1,101,675
Pfizer38$912,998
Takeda Pharmaceuticals U.S.A., Inc.87$909,298
Incyte Corporation290$723,426
UCB SA32$650,761
Sun Pharmaceutical Industries Inc.227$256,194
Novartis105$196,322
Boehringer Ingelheim12$180,374
Lilly USA, LLC140$163,847
Acrotech Biopharma Inc.18$148,346
Bristol Myers Squibb73$141,642
Avita Medical Americas, LLC7$128,940
GSK48$124,190
Eli Lilly6$123,986
Teva Pharmaceuticals USA, Inc.7$96,630
Bausch Health US, LLC11$80,918
Almirall LLC23$62,005
Regeneron128$50,466
Dermavant Sciences, Inc.48$33,803
E.r. Squibb & Sons, L.L.C.10$33,579
Sanofi Pasteur Inc.11$33,306
UCB, Inc.53$30,709
Sanofi US Services Inc.1$24,450
Taro Pharmaceuticals USA, Inc.2$14,000
Galderma Laboratories, L.p.19$12,929
Johnson & Johnson(2 entities)36$10,379
Boehringer Ingelheim International GmbH5$7,346
Arcutis Biotherapeutics, Inc.5$6,327
X4 Pharmaceuticals, Inc.8$4,647
Sanofi13$498
Regeneron Healthcare Solutions, Inc.15$386
Organogenesis Inc.7$308
Ortho Dermatologics, A Division Of Bausch Health US, LLC4$298
Janssen Scientific Affairs, LLC2$246
Surgical Specialties Corporation (US), Inc. (dba Corza Medical)1$196
LEO Pharma Inc.9$192
Botanix SB Inc1$154
EPI Health, LLC1$150
Amarin Pharma, Inc.1$130
Kyowa Kirin, Inc.2$113
Kerecis Limited1$86
VYNE Pharmaceuticals Inc.3$61
Sanofi-aventis U.S. LLC2$53
Mayne Pharma Commercial LLC1$29
Helsinn Therapeutics (U.S.), Inc.2$25
Biofrontera Inc.1$23
DUSA Pharmaceuticals, Inc.1$19
AstraZeneca1$17
Tactile Systems Technology Inc1$15
Dermira, Inc.1$15
Strata Skin Sciences, Inc.1$14

How this compares

$7,752,047 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California →

Medicare billing

Part B allowed, 2024
$3,016,233
Medicare patients
2,187
Services billed
13,905

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Thousand Oaks

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →